LRRK2 and Parkinson disease: We identified the upregulated proteins and phosphoproteins in NMC, iPD, and LRRK2 PD groups against the controls along with LRRK2 PD vs. NMC and LRRK2 PD vs. iPD (permutation-based FDR < 0.05 and log base 2 fold-change > 0.5, which equals to ~1.414 fold-change, see Supplementary Data 4 for the complete proteomic data and Supplementary Data 5 for the complete phosphoproteomic data).